HKSE - Delayed Quote HKD

WuXi Biologics (Cayman) Inc. (2269.HK)

23.100
+0.550
+(2.44%)
At close: May 9 at 4:08:05 PM GMT+8
All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
5,217,257
5,217,257
4,667,712
5,541,673
3,431,258
Investing Cash Flow
-3,941,706
-3,941,706
-3,228,266
-5,908,252
-9,601,670
Financing Cash Flow
-2,750,191
-2,750,191
1,961,163
-2,591,592
8,209,459
End Cash Position
8,279,182
8,279,182
9,669,839
6,395,222
9,003,280
Capital Expenditure
-3,929,621
-3,929,621
-4,230,514
-5,868,390
-6,523,114
Issuance of Capital Stock
19,392
19,392
26,158
36,180
11,035,309
Issuance of Debt
1,128,640
1,128,640
1,097,335
2,389,197
675,284
Repayment of Debt
-638,539
-638,539
-1,802,084
-2,563,130
-728,267
Repurchase of Capital Stock
-1,765,946
-1,765,946
-916,916
-2,804,454
-2,517,115
Free Cash Flow
1,287,636
1,287,636
437,198
-326,717
-3,091,856
12/31/2021 - 6/13/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers